Why the study?
Tobacco consumption is a major cardiovascular risk factor, but the effect of paan masala tobacco consumption has not been well studied.
Does pan masala tobacco consumption increase cardiovascular risk factors and correlate with urinary cotinine levels compared to nonusers?
Does pan masala tobacco consumption increase cardiovascular risk factors and correlate with urinary cotinine levels compared to nonusers?
Pan masala tobacco use is associated with worsened cardiovascular risk profiles, and urinary cotinine may serve as a useful screening tool for cardiovascular risk in these users.
Answers are grounded in this paper and cite their sources.
PMT use was associated with adverse CV risk factors; leaves open causal effects and cotinine screening utility.
BACKGROUND: Tobacco consumption is considered as one of the major risk factors for cardiovascular (CV) morbidity. However, the effect of paan masala tobacco (PMT) (a type of smokeless tobacco) consumption has not been well studied in our context. Our study is aimed to find an association of CV risk factors between PMT users and nonusers and to correlate those parameters with urinary cotinine level, a degradation product of nicotine occurring in tobacco. METHODS: test for categorical variable, independent t-test, Mann-Whitney U test, and Spearman's correlation applied for numerical variable, and multivariate regression analysis was performed as required. The level of significance was set at p < 0.05. RESULT: Mean BP, total cholesterol, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and median cotinine level were found to be significantly higher in PMT users than in controls (p < 0.001). Urinary cotinine level was positively correlated with mean BP, TC, TG, and LDL-C in PMT users (p < 0.001). Similarly, the odds of having hypercholesterolemia and increased diastolic BP was also significantly higher in PMT users (p < 0.001). CONCLUSION: PMT use has an adverse effect on CV risk parameters and there is a rational of cotinine measurement for screening CV risk among PMT users.
No takes yet. Share an insight, caveat, or question.
Shrestha et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: